Month: November 2017

ME Association Statement: Negative phase III clinical trial result from Norway for Rituximab in ME/CFS | 27 November 2017

“Despite the headline negative finding, we believe that this trial will still provide useful insights and contribute to a better understanding of M.E., and we also have the results from the Cyclophosphamide clinical trial to look forward to. We are very pleased that this knowledgeable, and valued, research team will continue with their work, trying to find answers to the M.E. puzzle.”

Advertising Standards Authority ruling on ME Association complaint re Kathy Kent and the Lightning Process | 15 November 2017

Background: When the SMILE trial results were published, the ME Associated stated that we would continue to refer cases where Lightning Process practitioners are making unproven therapeutic claims to the …

Advertising Standards Authority ruling on ME Association complaint re Kathy Kent and the Lightning Process | 15 November 2017 Read More »

“Our findings validate their symptoms — that their illness is real and has a biological basis.” Professor Jose Montoya | 09 November 2017

  This was a blog written by Ruthann Richter and published by Stanford Medicine, 8th November, 2017. For years, infectious disease expert Jose Montoya, MD, has been frustrated by the mysteries …

“Our findings validate their symptoms — that their illness is real and has a biological basis.” Professor Jose Montoya | 09 November 2017 Read More »

Shopping Cart